Haemonetics Corporation (HAE:NYSE) closed at $118.51 on October 23, 2026, up 2.02% on the day. The stock trades 4.2% below its 52-week high of $123.77 and 142.0% above its 52-week low of $48.98. Over the past year, it gained 131.2%. Haemonetics Corporation is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 23, 2025, HAE closed higher on 130 days (52%). Its best day was November 6, 2025 (+32.31%) and its worst was February 6, 2026 (-8.74%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 3 times.
Haemonetics Corporation, a healthcare company, provides products for processing, handling, and analysis of blood. The company operates through five segments: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection, filtration, and processing products. The company also offers hospital products comprising TEG thrombelastograph hemostasis analyzer system, a blood diagnostic instrument that measure a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system, a surgical blood salvage system for cardiovascular surgeries; and OrthoPAT surgical blood salvage systems for...
Find more stocks like HAE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.